Atlas Trials

Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream

Clinical trial NCT03914417 · COMPLETED

Trial details

NCT number
NCT03914417
Sponsor
Icahn School of Medicine at Mount Sinai
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Actinic Keratosis
Start date
2013-01-01
Primary completion
2015-04-30
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.